Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
30.72
+1.39 (4.74%)
Nov 4, 2025, 4:00 PM EST - Market closed
HRMY Market Cap
HRMY has a market cap or net worth of $1.77 billion as of November 4, 2025. Its market cap has decreased by -10.98% in one year.
Market Cap
1.77B
Enterprise Value
1.27B
1-Year Change
-10.98%
Ranking
Category
Stock Price
$30.72
Market Cap Chart
Since the IPO on August 19, 2020, HRMY's market cap has increased from $461.03M to $1.77B, an increase of 283.78%. That is a compound annual growth rate of 29.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 1.69B | -14.01% |
| Dec 31, 2024 | 1.96B | 3.73% |
| Dec 29, 2023 | 1.89B | -42.12% |
| Dec 30, 2022 | 3.27B | 31.09% |
| Dec 31, 2021 | 2.49B | 21.23% |
| Dec 31, 2020 | 2.06B | 346.07% |
| Aug 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 802.74B |
| Johnson & Johnson | 448.76B |
| AbbVie | 374.44B |
| UnitedHealth Group | 302.36B |
| AstraZeneca | 252.04B |
| Novartis AG | 236.44B |
| Novo Nordisk | 216.34B |
| Abbott Laboratories | 215.34B |